Montreal Heart Institute | GenomeWeb

Montreal Heart Institute

The genetics center has launched an NGS panel for inherited cardiovascular diseases and plans to develop pharmacogenomics and cholesterol metabolism panels.

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

The partners are using genomic data to improve understanding of cardiovascular disease and diabetes and identify markers linked to drug response.

The study found a strong association between the effects of dalcetrapib and a genetic variant in the gene ADCY9.

NEW YORK (GenomeWeb News) – The Montreal Heart Institute has partnered with several biotech companies and the Quebec government to launch a C$49.2 million (US$44.6 million) research program to that will use genetic and other biomarkers to develop personalized treatments for cardiovascular disease

By Monica Heger
This story was originally published Oct. 3.

Researchers at the institute have already used the system to sequence the TNNT2 gene in a number of clinical samples from a French Canadian cohort.

By bringing together genotyping and imputation data for more than 16,000 individuals with ulcerative colitis and about 32,600 unaffected controls, an international research team has identified 29 new loci linked to the inflammatory bowel disease.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.